Merck KGaA Statistics

Total Valuation

Merck KGaA has a market cap or net worth of GBP 46.05 billion. The enterprise value is 52.15 billion.

Market Cap	46.05B
Enterprise Value	52.15B

Important Dates

The last earnings date was Thursday, March 6, 2025.

Earnings Date	Mar 6, 2025
Ex-Dividend Date	Apr 28, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	-0.03%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	129.20M

Valuation Ratios

The trailing PE ratio is 20.05.

PE Ratio	20.05
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	12.43
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.78, with an EV/FCF ratio of 21.87.

EV / Earnings	22.71
EV / Sales	2.95
EV / EBITDA	10.78
EV / EBIT	15.26
EV / FCF	21.87

Financial Position

The company has a current ratio of 1.19, with a Debt / Equity ratio of 0.34.

Current Ratio	1.19
Quick Ratio	0.71
Debt / Equity	0.34
Debt / EBITDA	1.78
Debt / FCF	3.57
Interest Coverage	17.84

Financial Efficiency

Return on equity (ROE) is 9.82% and return on invested capital (ROIC) is 6.63%.

Return on Equity (ROE)	9.82%
Return on Assets (ROA)	5.10%
Return on Invested Capital (ROIC)	6.63%
Return on Capital Employed (ROCE)	10.15%
Revenue Per Employee	296,431
Profits Per Employee	38,910
Employee Count	59,020
Asset Turnover	0.42
Inventory Turnover	1.89

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -20.01% in the last 52 weeks. The beta is 0.74, so Merck KGaA's price volatility has been lower than the market average.

Beta (5Y)	0.74
52-Week Price Change	-20.01%
50-Day Moving Average	137.58
200-Day Moving Average	150.56
Relative Strength Index (RSI)	34.00
Average Volume (20 Days)	118,351

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Merck KGaA had revenue of GBP 17.50 billion and earned 2.30 billion in profits. Earnings per share was 5.28.

Revenue	17.50B
Gross Profit	10.36B
Operating Income	3.38B
Pretax Income	2.92B
Net Income	2.30B
EBITDA	4.78B
EBIT	3.38B
Earnings Per Share (EPS)	5.28

Full Income Statement

Balance Sheet

The company has 2.54 billion in cash and 8.52 billion in debt, giving a net cash position of -5.98 billion.

Cash & Cash Equivalents	2.54B
Total Debt	8.52B
Net Cash	-5.98B
Net Cash Per Share	n/a
Equity (Book Value)	24.80B
Book Value Per Share	56.89
Working Capital	1.78B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 3.79 billion and capital expenditures -1.41 billion, giving a free cash flow of 2.38 billion.

Operating Cash Flow	3.79B
Capital Expenditures	-1.41B
Free Cash Flow	2.38B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 59.20%, with operating and profit margins of 19.31% and 13.13%.

Gross Margin	59.20%
Operating Margin	19.31%
Pretax Margin	16.72%
Profit Margin	13.13%
EBITDA Margin	27.33%
EBIT Margin	19.31%
FCF Margin	13.63%

Dividends & Yields

This stock pays an annual dividend of 1.88, which amounts to a dividend yield of 1.43%.

Dividend Per Share	1.88
Dividend Yield	1.43%
Dividend Growth (YoY)	-3.19%
Years of Dividend Growth	n/a
Payout Ratio	37.13%
Buyback Yield	n/a
Shareholder Yield	1.43%
Earnings Yield	4.99%
FCF Yield	5.18%

Dividend Details

Stock Splits

The last stock split was on June 30, 2014. It was a forward split with a ratio of 2.

Last Split Date	Jun 30, 2014
Split Type	Forward
Split Ratio	2

Scores

Merck KGaA has an Altman Z-Score of 3.22.

Altman Z-Score	3.22
Piotroski F-Score	n/a